January 31, 2022

Understanding AI and Machine Learning’s Effect on Regulation and Litigation Risk

Product liability and mass torts attorneys Hannah Anderson, Christine Kain, Kevin Morrow and Theodore O’Reilly coauthored an article for the Defense Research Institute (DRI)’s For the Defense magazine titled “Understanding AI and Machine Learning’s Effect on Regulation and Litigation Risk.”

The article highlights the growing use of Artificial Intelligence (AI) and Machine Learning (ML) in medical applications and the Food and Drug Administration (FDA)’s evolving regulatory approach to AI and ML, including the FDA’s “Software as a medical device (SaMD) Action Plan.”

The authors also address the potential personal injury litigation risks for device manufacturers, noting that the potential allegations of software failures, inaccuracies, risk of hacking, and challenges must be weighed against the potential benefits of the devices.

全文
The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.